CEFTRIAXON Lagap 2000 mg i.v. / 2000 mg / 1 flacon
7680685350053
CH-68535
J01DD04
08.01.
Reimbursement limitations:
ROCEPHIN2
• Traitement ultérieur dans la pratique ambulatoire de l'ostéomyélite, des abscès pulmonaires et de l'endocardite.
…
1 / 3
google
Details
- Product number
- 6853503
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- ceftriaxonum 2000 mg ut ceftriaxonum natricum, pro vitro corresp. natrium 166 mg.
Articles (1)
Ceftriaxon Lagap 2000 mg i.v., Polvere per soluzione per infusione
polvere per soluzione per infusione
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
2000.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
166.0 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 27.20
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/07/2025
Authorization holder
Lagap SA
6943 Vezia
Authorization information
- Swissmedic authorization number
- 68535
- Drug name
- Ceftriaxon Lagap, Polvere per soluzione iniettabile/per infusione
- Galenic form
- PULVII
- ATC Code
- J01DD04
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 24/11/2022
- Authorization expiration date
- 23/11/2027
- IT number
- 08.01.
- Domain
- Human medicine
Packaging details
- Description (FR)
- CEFTRIAXON Lagap 2000 mg i.v. / 2000 mg / 1 flacon
- Description (DE)
- CEFTRIAXON Lagap 2000 mg i.v. / 2000 mg / 1 Durchs
- Market launch
- 24/11/2022
- Narcotic (BTM)
- No
Original drug
Rocephin, Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung
GTIN:
7680446250011
CHF 21.05